NASDAQ:XRAY - DENTSPLY SIRONA Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
News Sentiment
About
FAQ

Consensus Rating: Hold
Consensus Price Target: $50.56
Forecasted Upside: 39.66 %
Number of Analysts: 10
Breakdown:
0 Sell Ratings
6 Hold Ratings
4 Buy Ratings
0 Strong Buy Ratings

^$36.20 As of 07/1/2022 05:01 PM ET

▲ +0.47 (1.32%)

1 month | 3 months | 12 months

Get New DENTSPLY SIRONA Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for XRAY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for XRAY

^$50.56

▲ +39.66% Upside Potential

This price target is based on 10 analysts offering 12 month price targets for DENTSPLY SIRONA in the last 3 months. The average price target is $50.56, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 39.66% upside from the last price of $36.20.

Current Consensus is Hold

The current consensus among 10 investment analysts is to hold stock in DENTSPLY SIRONA. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
6 buy ratings
8 hold ratings
1 sell ratings

Ratings as of

1/10/2021

0 strong buy ratings
5 buy ratings
7 hold ratings
1 sell ratings

Ratings as of

4/10/2021

0 strong buy ratings
2 buy ratings
6 hold ratings
1 sell ratings

Ratings as of

7/9/2021

0 strong buy ratings
2 buy ratings
4 hold ratings
1 sell ratings

Ratings as of

10/7/2021

0 strong buy ratings
1 buy ratings
3 hold ratings
1 sell ratings

Ratings as of

1/5/2022

0 strong buy ratings
3 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

4/5/2022

0 strong buy ratings
4 buy ratings
6 hold ratings
0 sell ratings

Ratings as of

6/4/2022

0 strong buy ratings
4 buy ratings
6 hold ratings
0 sell ratings

Ratings as of

7/4/2022

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
6/1/2022	UBS Group	Upgrade	Neutral ➝ Buy	$58.00 ➝ $47.00	High
5/11/2022	Barrington Research	Lower Price Target		$53.00 ➝ $51.00	Medium
4/22/2022	HC Wainwright	Lower Price Target	Hold	$58.00 ➝ $48.00	Medium
4/21/2022	The Goldman Sachs Group	Lower Price Target	Neutral	$59.00 ➝ $47.00	Medium
4/20/2022	Morgan Stanley	Lower Price Target	Overweight	$62.00 ➝ $52.00	Low
4/20/2022	Barrington Research	Lower Price Target		$72.00 ➝ $53.00	High
4/20/2022	Piper Sandler	Reiterated Rating	Overweight ➝ Neutral	$71.00 ➝ $46.00	Medium
4/19/2022	Bank of America	Downgrade	Buy ➝ Neutral	$66.00 ➝ $49.00	High
4/19/2022	William Blair	Downgrade	Outperform ➝ Market Perform		High
4/19/2022	Robert W. Baird	Downgrade	Outperform ➝ Neutral	$67.00 ➝ $48.00	High
3/1/2022	The Goldman Sachs Group	Lower Price Target	Neutral	$66.00 ➝ $59.00	High
3/1/2022	Barrington Research	Lower Price Target		$79.00 ➝ $72.00	High
3/1/2022	Credit Suisse Group	Lower Price Target	Outperform	$68.00 ➝ $67.00	High
3/1/2022	HC Wainwright	Lower Price Target		$66.00 ➝ $58.00	Low
2/18/2022	Robert W. Baird	Lower Price Target	Outperform	$78.00 ➝ $67.00	High
1/31/2022	Morgan Stanley	Initiated Coverage	Overweight	$62.00	Low
8/9/2021	HC Wainwright	Lower Price Target	Neutral	$72.00 ➝ $66.00	Low
8/6/2021	Barrington Research	Boost Price Target	Outperform	$77.00 ➝ $79.00	Low
5/7/2021	Barrington Research	Boost Price Target	Outperform	$71.00 ➝ $77.00	Low
5/7/2021	Robert W. Baird	Boost Price Target	Outperform	$71.00 ➝ $78.00	Medium
5/7/2021	HC Wainwright	Boost Price Target	Neutral	$60.00 ➝ $72.00	Medium
5/6/2021	Piper Sandler	Boost Price Target	Overweight	$70.00 ➝ $75.00	Medium
3/2/2021	Barclays	Boost Price Target	Underweight	$50.00 ➝ $55.00	Medium
3/2/2021	Robert W. Baird	Boost Price Target	Outperform	$62.00 ➝ $71.00	Medium
3/2/2021	Barrington Research	Upgrade	Market Perform ➝ Outperform	$71.00	Medium
3/2/2021	HC Wainwright	Reiterated Rating	Neutral	$55.00 ➝ $60.00	Low
3/1/2021	Piper Sandler	Boost Price Target	Overweight	$63.00 ➝ $70.00	Low
1/5/2021	Robert W. Baird	Boost Price Target	Outperform	$58.00 ➝ $62.00	N/A
1/5/2021	Barclays	Boost Price Target	Underweight	$40.00 ➝ $44.00	N/A
1/5/2021	HC Wainwright	Boost Price Target	Neutral	$49.00 ➝ $55.00	N/A
12/18/2020	Stifel Nicolaus	Downgrade	Buy ➝ Hold	$52.00	Low
12/15/2020	Piper Sandler	Boost Price Target	Overweight	$51.00 ➝ $61.00	High
11/17/2020	Barclays	Downgrade	Equal Weight ➝ Underweight	$40.00	Low
11/9/2020	HC Wainwright	Boost Price Target	Neutral	$45.00 ➝ $49.00	High
10/22/2020	Guggenheim	Upgrade	Neutral ➝ Buy		High
10/5/2020	JPMorgan Chase & Co.	Boost Price Target	Neutral	$45.00 ➝ $47.00	Medium
8/10/2020	HC Wainwright	Lower Price Target	Neutral	$50.00 ➝ $45.00	Low
7/20/2020	Bank of America	Boost Price Target	Buy	$54.00 ➝ $56.00	Medium
6/16/2020	Piper Sandler	Initiated Coverage	Overweight	$51.00	Low
6/15/2020	HC Wainwright	Boost Price Target	Neutral	$38.00 ➝ $50.00	Medium
5/27/2020	Evercore ISI	Upgrade	In-Line ➝ Outperform	$50.00	High
5/14/2020	Cfra	Lower Price Target	Hold	$53.00 ➝ $38.00	High
5/11/2020	Barclays	Lower Price Target	Equal Weight	$42.00 ➝ $40.00	High
5/11/2020	UBS Group	Lower Price Target	Neutral	$59.00 ➝ $44.00	High
5/11/2020	Barrington Research	Downgrade	Outperform ➝ Market Perform		Low
4/24/2020	HC Wainwright	Lower Price Target	Neutral	$51.00 ➝ $38.00	Medium
4/19/2020	Credit Suisse Group	Reiterated Rating	Buy	$50.00	Low
4/19/2020	Robert W. Baird	Upgrade	Neutral ➝ Outperform		Low
4/8/2020	Robert W. Baird	Upgrade	Neutral ➝ Outperform	$57.00 ➝ $49.00	Medium
4/7/2020	The Goldman Sachs Group	Downgrade	Buy ➝ Neutral	$58.00 ➝ $40.00	Medium
4/2/2020	Wolfe Research	Upgrade	Peer Perform ➝ Outperform	$66.00	Low
3/17/2020	JPMorgan Chase & Co.	Lower Price Target	Neutral	$65.00 ➝ $45.00	High
3/13/2020	Stifel Nicolaus	Lower Price Target	Buy	$66.00 ➝ $56.00	Low
3/11/2020	The Goldman Sachs Group	Downgrade	Conviction-Buy ➝ Buy		Low
3/3/2020	Barrington Research	Lower Price Target	Outperform	$63.00 ➝ $60.00	Medium
3/3/2020	Robert W. Baird	Lower Price Target	Neutral	$61.00 ➝ $57.00	High
3/3/2020	HC Wainwright	Reiterated Rating	Neutral	$60.00 ➝ $51.00	High
2/19/2020	Stifel Nicolaus	Boost Price Target	Buy	$63.00 ➝ $66.00	Medium
1/19/2020	Barclays	Reiterated Rating	Hold	$64.00	Medium
12/11/2019	JPMorgan Chase & Co.	Downgrade	Overweight ➝ Neutral	$65.00	Low
11/15/2019	HC Wainwright	Reiterated Rating	Hold	$60.00	Low
8/5/2019	Barrington Research	Reiterated Rating	Buy	$63.00	High
8/2/2019	Wellington Shields	Upgrade	Hold ➝ Gradually Accumulate		High
7/26/2019	Evercore ISI	Initiated Coverage	In-line ➝ In-Line		Low
7/9/2019	HC Wainwright	Reiterated Rating	Neutral ➝ Neutral	$55.00 ➝ $57.00	Low
5/30/2019	Wolfe Research	Initiated Coverage	Peer Perform ➝ Peer Perform		Low
5/6/2019	Barrington Research	Upgrade	Market Perform ➝ Outperform	$63.00	Medium
5/6/2019	HC Wainwright	Reiterated Rating	Neutral ➝ Neutral	$49.00 ➝ $55.00	Low
4/17/2019	Guggenheim	Initiated Coverage	Neutral ➝ Neutral	$54.00	High
4/5/2019	HC Wainwright	Set Price Target	Hold	$49.00	Low
3/18/2019	Bank of America	Initiated Coverage	Buy	$57.00	Low
3/18/2019	William Blair	Upgrade	Market Perform ➝ Outperform	$56.71	Medium
3/12/2019	UBS Group	Boost Price Target	Neutral ➝ Neutral	$42.00 ➝ $53.00	Low
3/4/2019	Robert W. Baird	Boost Price Target	Neutral ➝ Neutral	$42.00 ➝ $50.00	Medium
3/4/2019	HC Wainwright	Reiterated Rating	Neutral ➝ Neutral	$40.00 ➝ $49.00	Low
3/1/2019	William Blair	Upgrade	Market Perform ➝ Outperform		Low
3/1/2019	Barclays	Set Price Target	Hold	$49.00	Low
1/17/2019	UBS Group	Initiated Coverage	Neutral ➝ Neutral	$42.00	Low
1/6/2019	Barclays	Reiterated Rating	Hold	$39.00	Medium
11/9/2018	Barrington Research	Reiterated Rating	Hold		Medium
10/19/2018	The Goldman Sachs Group	Upgrade	Sell ➝ Buy	$44.00	High
8/31/2018	HC Wainwright	Set Price Target	Hold	$40.00	Medium
8/9/2018	Barrington Research	Downgrade	Outperform ➝ Market Perform		Low
8/8/2018	Barclays	Lower Price Target	Equal Weight ➝ Equal Weight	$55.00 ➝ $41.00	Medium
8/8/2018	Jefferies Financial Group	Lower Price Target	Buy ➝ Buy	$58.00 ➝ $46.00	Medium
8/8/2018	Stifel Nicolaus	Lower Price Target	Buy ➝ Buy	$57.00 ➝ $46.00	Medium
8/8/2018	HC Wainwright	Reiterated Rating	Hold	$40.00	Medium
8/8/2018	Morgan Stanley	Downgrade	Overweight ➝ Equal Weight	$54.00 ➝ $40.00	Medium
8/8/2018	Stephens	Downgrade	Overweight ➝ Equal Weight	$75.00	Medium
8/7/2018	Robert W. Baird	Downgrade	Outperform ➝ Neutral	$56.00 ➝ $38.00	High
6/14/2018	Morgan Stanley	Lower Price Target	Overweight ➝ Overweight	$65.00 ➝ $54.00	Low
6/5/2018	Northcoast Research	Downgrade	Buy ➝ Neutral		High
5/16/2018	Deutsche Bank Aktiengesellschaft	Lower Price Target	Buy	$55.00	Low
5/8/2018	Robert W. Baird	Lower Price Target	Outperform ➝ Outperform	$71.00	High
5/8/2018	Barrington Research	Lower Price Target	Outperform ➝ Outperform	$70.00 ➝ $54.00	High
5/8/2018	Barclays	Reiterated Rating	Hold	$55.00	High
5/8/2018	Stifel Nicolaus	Reiterated Rating	Buy ➝ Buy	$67.00 ➝ $57.00	High
5/8/2018	HC Wainwright	Lower Price Target	Neutral ➝ Neutral	$63.00 ➝ $52.00	High
4/16/2018	Jefferies Financial Group	Reiterated Rating	Buy		Low
4/5/2018	Cleveland Research	Reiterated Rating	Hold		Low
3/27/2018	Barrington Research	Reiterated Rating	Buy	$69.00	Medium
3/27/2018	HC Wainwright	Set Price Target	Hold	$63.00	Medium
3/8/2018	Barclays	Initiated Coverage	Equal Weight ➝ Equal Weight	$62.00	Low
3/5/2018	JPMorgan Chase & Co.	Lower Price Target	Overweight ➝ Overweight	$75.00 ➝ $70.00	Low
3/5/2018	Barrington Research	Reiterated Rating	Outperform ➝ Outperform	$73.00 ➝ $70.00	Low
3/5/2018	HC Wainwright	Set Price Target	Neutral ➝ Hold	$68.00 ➝ $63.00	Medium
3/2/2018	Credit Suisse Group	Lower Price Target	Outperform ➝ Outperform	$73.00 ➝ $69.00	High
1/18/2018	HC Wainwright	Reiterated Rating	Hold	$68.00	Low
1/5/2018	Credit Suisse Group	Downgrade	Hold	$73.00	Medium
12/13/2017	JPMorgan Chase & Co.	Upgrade	Neutral ➝ Overweight	$75.00	Medium
12/8/2017	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Buy ➝ Buy	$81.00	Low
12/7/2017	HC Wainwright	Reiterated Rating	Hold	$68.00	Low
11/30/2017	HC Wainwright	Downgrade	Buy ➝ Neutral	$68.00	Medium
11/28/2017	Stephens	Initiated Coverage	Overweight	$75.00	Low
11/6/2017	Stifel Nicolaus	Boost Price Target	Buy	$66.00 ➝ $70.00	N/A
11/6/2017	HC Wainwright	Reiterated Rating	Buy	$68.00	N/A
11/6/2017	Barrington Research	Upgrade	Market Perform ➝ Outperform	$73.00	N/A
10/19/2017	Robert W. Baird	Set Price Target	Buy	$63.00	N/A
10/19/2017	Stifel Nicolaus	Reiterated Rating	Buy		N/A
10/6/2017	Morgan Stanley	Reiterated Rating	Overweight	$67.00 ➝ $69.00	N/A
10/5/2017	Cleveland Research	Downgrade	Buy ➝ Neutral		N/A
10/3/2017	HC Wainwright	Reiterated Rating	Buy	$68.00	Low
8/23/2017	Jefferies Financial Group	Lower Price Target	Buy	$72.00 ➝ $66.00	High
8/14/2017	HC Wainwright	Reiterated Rating	Buy ➝ Buy	$74.00 ➝ $68.00	Medium
8/10/2017	UBS Group	Reiterated Rating	Neutral	$62.00 ➝ $59.00	Low
8/10/2017	Morgan Stanley	Boost Price Target	Overweight	$66.00 ➝ $67.00	Low
8/10/2017	Stifel Nicolaus	Reiterated Rating	Buy	$70.00 ➝ $66.00	Low
7/13/2017	Credit Suisse Group	Reiterated Rating	Outperform	$67.00 ➝ $75.00	Low
7/11/2017	HC Wainwright	Initiated Coverage	Buy ➝ Buy	$74.00	Low

(Data available from 7/5/2017 forward)

News Sentiment Rating

0.20 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

1 very positive mentions
17 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

12/6/2021

1 very positive mentions
4 positive mentions
1 negative mentions
0 very negative mentions

Mentions as of

1/5/2022

2 very positive mentions
3 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

2/4/2022

7 very positive mentions
9 positive mentions
4 negative mentions
0 very negative mentions

Mentions as of

3/6/2022

1 very positive mentions
22 positive mentions
1 negative mentions
0 very negative mentions

Mentions as of

4/5/2022

3 very positive mentions
20 positive mentions
2 negative mentions
0 very negative mentions

Mentions as of

5/5/2022

8 very positive mentions
39 positive mentions
5 negative mentions
4 very negative mentions

Mentions as of

6/4/2022

2 very positive mentions
10 positive mentions
5 negative mentions
1 very negative mentions

Mentions as of

7/4/2022

Current Sentiment

Recent Stories by Sentiment

DENTSPLY SIRONA Inc. designs, develops, manufactures, distributes, and sells various dental products and technologies for professional dental market worldwide. It offers dental equipment, including treatment centers, imaging equipment, motorized dental handpieces, and other instruments; imaging equipment; treatment centers comprising basic dentist chairs, sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, and specialist centers; and lab equipment, such as amalgamators, mixing machines, and porcelain furnaces. The company also provides dental CAD/CAM products, digital impressions intraoral scanners, mills, and services; and orthodontic products, including high frequency vibration technology device under the name VPro, dentist-directed clear aligner solutions under the name SureSmile, and direct-to-consumer clear aligner solutions under the name Byte; dental implant products, bone regenerative and restorative solutions, and educational programs; and urology catheters and other healthcare-related consumable products. In addition, it offers endodontic products comprising endodontic instruments and materials, drills, filers, sealers, irrigation needles, and other tools or single-use solutions; restorative products that include dental prosthetics, such as artificial teeth, dental ceramics, digital dentures, precious metal dental alloys, and crown and bridge porcelain products; small equipment products comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers; and dental supplies, including dental anesthetics, prophylaxis paste, dental sealants, impression materials, teeth whiteners, and topical fluoride. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1899 and is headquartered in Charlotte, North Carolina.

Today's Range

Now: $36.20

$35.34

$36.25

50 Day Range

MA: $38.32

$34.74

$41.95

52 Week Range

Now: $36.20

$33.78

$66.98

Volume

65,360 shs

Average Volume

2,284,170 shs

Market Capitalization

$7.80 billion

P/E Ratio

21.42

Dividend Yield

1.38%

Beta

0.94

Frequently Asked Questions

What sell-side analysts currently cover shares of DENTSPLY SIRONA?: The following Wall Street research analysts have issued research reports on DENTSPLY SIRONA in the last twelve months: Bank of America Co., Barrington Research, Credit Suisse Group AG, HC Wainwright, Morgan Stanley, Piper Sandler, Robert W. Baird, StockNews.com, The Goldman Sachs Group, Inc., TheStreet, UBS Group AG, and William Blair.
View the latest analyst ratings for XRAY.
What is the current price target for DENTSPLY SIRONA?: 0 Wall Street analysts have set twelve-month price targets for DENTSPLY SIRONA in the last year. Their average twelve-month price target is $50.56, suggesting a possible upside of 39.7%.
View the latest price targets for XRAY.
What is the current consensus analyst rating for DENTSPLY SIRONA?: DENTSPLY SIRONA currently has 6 hold ratings and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in XRAY, but not buy more shares or sell existing shares.
View the latest ratings for XRAY.
What other companies compete with DENTSPLY SIRONA?: Other companies that are similar to DENTSPLY SIRONA include West Pharmaceutical Services, Align Technology, Cooper Companies, QuidelOrtho, ICU Medical, Haemonetics, STAAR Surgical, Merit Medical Systems, Neogen, Meridian Bioscience, Atrion, Cerus, Antares Pharma, Anika Therapeutics and Utah Medical Products. Learn More about companies similar to DENTSPLY SIRONA.
How do I contact DENTSPLY SIRONA's investor relations team?: DENTSPLY SIRONA's physical mailing address is 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC, 28277. The medical instruments supplier's listed phone number is (844) 848-0137 and its investor relations email address is [email protected] The official website for DENTSPLY SIRONA is www.dentsplysirona.com. Learn More about contacing DENTSPLY SIRONA investor relations.

NASDAQ:XRAY - DENTSPLY SIRONA Stock Price Target and Predictions

Analyst Price Target for XRAY

Current Consensus is Hold

Past Monthly Recommendations

Latest Recommendations

News Sentiment Rating

0.20 (Hold)

News Sentiment Over Time

Current Sentiment

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of DENTSPLY SIRONA?

What is the current price target for DENTSPLY SIRONA?

What is the current consensus analyst rating for DENTSPLY SIRONA?

What other companies compete with DENTSPLY SIRONA?

How do I contact DENTSPLY SIRONA's investor relations team?